« Previous
Next »
Diagnostic Microbiology & Infectious Disease
Volume 67, Issue 3
, Pages 277-281
, July 2010
Epidemiology of Escherichia coli clinical isolates producing AmpC plasmidic β-lactamase during a 5-year period in a French teaching Hospital
References
- . Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases in Lugo (Spain): Dissemination of clone O25b:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 2009;63:1135–1141
- . Analysis of the effect of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC. J. Antimicrob. Chemother. 2000;45:783–788
- . Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 2000;66:4555–4558
- . Most Escherichia coli strains overproducing chromosomal AmpC β-lactamase belong to phylogenetic group A. J. Antimicrob. Chemother. 2007;60:872–876
- . The prevalence of plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China. Eur. J. Clin. Microbiol. Infect. Dis. 2008;27:915–921
- . MLST typing of Escherichia coli isolates overproducing AmpC β-lactamase. J. Antimicrob. Chemother. 2009;63:1290–1292
- . The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC. J. Antimicrob. Chemother. 2008;62:694–702
- . AmpC β-lactamases. Clin. Microbiol. Rev. 2009;22:161–182
- . ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of β-lactamases of the penicillinase type. Proc. Natl. Acad. Sci. U. S. A. 1981;78:4897–4901
- . Absence of CTX-M enzymes but high prevalence of clones, including clone ST 131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France.. J. Clin. Microbiol. 2008;46:3900–3905
- . Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital. J. Antimicrob. Chemother. 2008;61:498–503
- . Characterization of cefoxitin-resistant Escherichia coli isolated from recreational beaches and private drinking water in Canada between 2004 and 2006. Antimicrob. Agents Chemother. 2009;53:3126–3130
- . Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob. Agents Chemother. 2005;49:358–365
- . Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway. Clin. Microbiol. Infect. 2010;16:171–178
- . Multilocus sequence typing reveals a lack of diversity among Escherichia coli O157:H7 isolates that are distinct by pulsed-field gel electrophoresis. J. Clin. Microbiol. 2003;41:675–679
- . Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23complex/A and ST131/B2. Int. J. Antimicrob. Agents. 2009;34:173–176
- . Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 2002;40:2153–2162
- . Clinical features and molecular epidemiology of CMY-type β-lactamase-producing Escherichia coli. Clin. Infect. Dis. 2009;48:739–744
- . Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 1995;33:2233–2239
☆ This work was partially funded by grants from the Ministère de l’Education Nationale et de la Recherche (EA3826), Universités de Nantes, France.
PII: S0732-8893(10)00043-X
doi: 10.1016/j.diagmicrobio.2010.02.007
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
Diagnostic Microbiology & Infectious Disease
Volume 67, Issue 3
, Pages 277-281
, July 2010
